MAPT and Cognitive impairment: Therefore, the lower levels of pS-α-syn-RBC detected in the patients with cognitive impairment and olfactory loss may not be due to the actual reduction of pS-α-syn-RBC but rather to its interaction with Aβ and tau, which affects its accurate detection.